EverCommerce (EVCM) Q1 2026 earnings review
Slower Growth and Margin Compression Masked by Lower Interest Expenses
EverCommerce delivered a lackluster Q1 2026. While revenue grew 3.6% YoY to $147.5M, this marks a steady deceleration from the ~5.3% growth seen in mid-2025. More alarmingly, the company's previously celebrated margin expansion has reversed: Adjusted EBITDA fell 9.4% YoY to $40.7M. Net Income jumped to $7.2M (up from $0.9M a year ago), but this was entirely driven by an $8.0M reduction in interest expenses, not operational leverage. Management is promising a back-half acceleration fueled by AI products and payments cross-selling, but Q2 guidance implies continued deceleration in the near term.
🐂 Bull Case
Debt restructuring and paydowns are working. Interest and other expenses dropped from $12.8M in 25Q1 to just $4.8M in 26Q1, allowing more cash to flow directly to the bottom line.
Management reaffirmed FY26 guidance, implying they expect a sharp reacceleration in growth and profitability in the second half of the year as new AI tools and payment integrations gain traction.
🐻 Bear Case
Adjusted EBITDA margin compressed to 27.6% from 31.6% a year ago. The 'transformation and optimization' margin expansion story of 2025 has clearly stalled.
With Q1 revenue growth at 3.6% and Q2 guidance pointing toward ~2.7% growth, the underlying business is slowing. Legacy payment solutions acting as a drag on newer, high-growth products remain a persistent issue.
⚖️ Verdict: 🔴
Bearish. The headline Net Income improvement is an accounting reality, but the operational reality is declining EBITDA margins and slowing top-line growth. The pressure is entirely on a back-half "hockey stick" recovery that carries significant execution risk.
Key Themes
EBITDA Beat Masks Structural Contraction
Management highlighted that Q1 results 'exceeded the midpoint of the guidance range' for Adjusted EBITDA. However, a deeper look at the data contradicts the positive tone: Adjusted EBITDA dropped 9.4% YoY to $40.7M, and margins compressed by 400 basis points (from 31.6% to 27.6%). Beating lowered guidance does not negate the fact that operational profitability is deteriorating.
AI-First Transformation
EverCommerce is shifting from 'bolting on' third-party tools to building native AI agentic features. Key innovations include EverHealth Scribe (which saves doctors an average of 8 minutes per patient) and ZyraTalk's intelligent no-show predictor (reducing no-shows by 60%). While direct monetization currently lags, these tools are designed to increase ARPU and command pricing power during future renewals.
High-Margin Payments Cross-Sell
Payments remain the primary growth engine. With gross margins near 95%, attaching payments to the initial SaaS sale ('front-book attach') is management's highest priority. Multi-solution customers show NRR above 100%, and driving this cohort is essential to counteracting churn in the legacy portfolio.
Legacy Portfolio Drag and NRR
The company continues to suffer from a bifurcated portfolio. While top-tier solutions grow well, the older, mature segment of the customer base exhibits higher churn and lower payment adoption. This dynamic kept the trailing 12-month Net Revenue Retention (NRR) hovering around 96% in recent quarters, meaning EverCommerce must aggressively add new logos just to tread water.
Macro and Tariff Uncertainty in Home Services
Despite management's general optimism, the EverPro vertical (HVAC, plumbing) remains exposed to macroeconomic pressures and potential tariffs. In late 2025, these factors caused explicit softness in usage-based rebate programs. If consumer spending on home improvement tightens further, the core SaaS business could see heightened churn.
Other KPIs
A massive improvement. This expense plummeted from $12.8 million in 25Q1, representing an $8.0 million savings. This single line item is the only reason EverCommerce reported YoY Net Income growth in Q1.
Stable. The company continues to return capital to shareholders, utilizing cash flow to buy back stock at an average price of roughly $10.69 per share. $33.9 million remains on the current authorization.
Accelerating investment. The capitalized software balance grew from $58.9 million at year-end 2025, reflecting the heavy upfront cash investments required for the company's AI pivot (ZyraTalk integration and agentic features). This will weigh on Free Cash Flow in the near term.
Guidance
Decelerating. The $152.0M midpoint implies just 2.7% YoY growth compared to 25Q2 ($148.0M). This is a further step down from the 3.6% growth achieved in 26Q1.
Reversing. The $42.0M midpoint implies a 6.7% decline YoY compared to $45.0M in 25Q2. The margin profile is expected to remain stuck in the mid-27% range.
Accelerating implicitly. To hit the $622M midpoint (which implies 5.6% annual growth), the company will need to deliver significant sequential and YoY growth acceleration in Q3 and Q4. Management is betting heavily on H2 execution.
Accelerating implicitly. The $187.0M midpoint implies 3.6% annual growth. Given the YoY declines in Q1 and expected in Q2, this guidance requires a dramatic margin recovery in the second half of the year.
Key Questions
Bridging the H2 Growth Gap
With Q1 delivering 3.6% revenue growth and Q2 guiding to ~2.7%, hitting your 5.6% FY guidance requires a massive H2 acceleration. What specific, tangible catalysts give you confidence in this hockey-stick trajectory?
Adjusted EBITDA Margin Compression
Adjusted EBITDA margins compressed by 400 basis points YoY in Q1. Is this entirely due to planned strategic investments in AI and GTM, or are you seeing pricing pressure and rising customer acquisition costs?
Legacy Portfolio Drag
Can you provide an update on the growth divergence between your top-six growth solutions and the legacy payment portfolio? Is the legacy drag accelerating or stabilizing?
AI Monetization Timeline
You've invested heavily in tools like EverHealth Scribe and ZyraTalk. When do you expect these features to transition from 'retention tools' to direct drivers of ARPU and revenue expansion?